|Bid||4.0500 x 0|
|Ask||4.0600 x 0|
|Day's Range||4.0100 - 4.1500|
|52 Week Range||0.1550 - 6.3300|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||25.96|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.53|
Canopy Growth Corp. is not outright acquiring Acreage Holdings Inc., as reports said Wednesday, but it is preparing to pay billions for the rights to buy the U.S.-based pot company.
TORONTO, April 16, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers") (RIV.V) and High Beauty, Inc. ("High Beauty") are pleased to announce the completion of an investment by Canopy Rivers in High Beauty, creator of industry-leading cannabis beauty brand high. Canopy Rivers has subscribed for US$2.5 million of shares in High Beauty, representing 18.4% of the company on a fully diluted basis, including additional warrant coverage. "Being supported by Canopy Rivers enables us to collaborate within the Canopy Rivers ecosystem and to focus our energy and passion on the creation of a robust new product line using cannabis-derived extracts," said Melissa Jochim, a highly successful formulator and Founder of High Beauty.
TORONTO , April 1, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (JWCA.V) (JWCAF), has received its cultivation licence from Health Canada for its Kitchener-based commercial scale production facility ("JWC2"). This second licence launches the initial phase of JWC2, a 345,000 square foot production and distribution complex where JWC is rolling out more than 130 individual production rooms utilizing JWC's proprietary GrowthSTORM™ Dual Droplet cultivation platform and methodologies.
Canopy Rivers Inc (OTCMKTS:CNPOF) has announced that it was awarded a cannabis growth license for both Canopy Growth Corp (NYSE:CGC) and also its portfolio firm called Spot Therapeutics. The Health Canada cultivation license will facilitate production and distribution of cannabis at Canopy’s facility in Fredericton. The announcement also revealed that the license will allow the […]The post Canopy Rivers Secures Cannabis Growth License From Health Canada appeared first on Market Exclusive.
Investorideas.com, a leading investor news resource covering tech and cannabis stocks, releases a snapshot looking at how payment technology and data solutions have evolved due to the regulatory hurdles facing the cannabis industry. PaymentsJournal discussed the “cannabis payments conundrum” and how as the cannabis industry matures we are beginning to see an evolution in payment and data tech companies. From the article: “The next few years will be hugely important in bringing more validity to the cannabis industry as it continues to expand into new legalized markets.
Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (RIV.V) congratulates Canopy Growth Corporation (WEED.TO) (CGC) (“Canopy Growth”) and its portfolio company, Spot Therapeutics Inc. (“Spot”), on receiving a cultivation license from Health Canada for its Fredericton-based production and distribution facility. In 2017, Canopy Growth solidified its expansion strategy in Atlantic Canada when it acquired Spot and made significant local funding commitments in collaboration with Canopy Rivers, ultimately resulting in Canopy Growth being rewarded with one of the first provincial supply contracts in the cannabis industry, pursuant to a landmark MOU with the government of New Brunswick.
SMITHS FALLS , ON and FREDERICTON, NB , March 25, 2019 /CNW/ - Canopy Growth Corporation (TSX: WEED), (NYSE: CGC) ("Canopy Growth" or the "Company") is pleased to announce that it has received a cultivation licence from Health Canada for its facility in Fredericton, New Brunswick . With this licensing, Canopy Growth predicts the facility will initially produce more than 5,000kg of cannabis annually, with first harvests expected to become available to the market within six months. Developed in collaboration with Canopy Rivers Inc. (RIV.V) and operating under Canopy Growth's flagship Tweed brand, the facility will support the Company's global and local operations with high quality, large-scale cannabis production capabilities that will serve the needs of recreational and medical customers.
Following Canada's country-wide legalization back in October 2018, the cannabis industry has used the momentum gained from Canada's legislation to demonstrate, on a global scale, the economic benefits of investing in cannabis companies. Leafbuyer Technologies Inc (OTC:LBUY), Acreage Holdings Inc (ACRGF), Canopy Rivers Inc (OTC PINK: CNPOF) (RIV.V), The Yield Growth Corp (OTCQB:BOSQF) represent 4 marijuana stocks leading the industry on Wednesday. In recognition of this growing trend to do one's homework, Leafbuyer has become the authority on cannabis-related information.
POINT ROBERTS, Wash. and DELTA, British Columbia, March 19, 2019 -- Investorideas.com, a leading investor news resource covering tech and cannabis stocks releases a snapshot.
Completed capital reorganization with the continued support of Canopy Growth Corp. (WEED.TO) (NYSE: CGC), Canopy Rivers Corp. (RIV.V) and funds controlled by Jason Wild , Chairman of the Company, allowing the Company to pursue US expansion. In addition, the company will be opening its first East Coast Apothecarium location in Philipsburg , NJ in Q4 2019. The Company continued to drive sales for its adult-use brand, Haven St. Premium Cannabis, a top-10 selling brand in the five Canadian provincial jurisdictions where it is sold.
Canopy Rivers Inc. (“Canopy Rivers”) (RIV.V) and LeafLink, Inc. (“LeafLink”) are pleased to announce the establishment of LeafLink Services International ULC (“LeafLink International”), a new venture that exclusively licenses and leverages LeafLink’s dominant business-to-business (B2B) marketplace and supply chain technology platform for deployment throughout regulated international cannabis markets. LeafLink is a software-as-a-service (SaaS) marketplace that simplifies the supply chain through its e-commerce platform.
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) congratulates its portfolio company Headset, Inc. (“Headset”) on the formation of its landmark strategic alliance with Nielsen Holdings plc (“Nielsen”) (NLSN). Yesterday, Nielsen and Headset together announced an alliance that will provide U.S. cannabis market data and analytics to consumer packaged goods (CPG) companies monitoring the cannabis space.
DETROIT, March 6, 2019 /PRNewswire/ -- Precision Extraction Corporation (DBA Precision Extraction Solutions, "Precision" or "the Company"), a market leader in cannabis and hemp extraction technology, is pleased to announce it has received a significant capital investment from Rivers Innovations Inc. ("Rivers Innovations"), a private U.S. focused growth capital and strategic support platform founded and advised by the seed investment and strategic advisory group behind Canopy Rivers Inc. (RIV.V).
Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (RIV.V) today released its financial results for the three and nine months ended December 31, 2018. The Company’s full Management's Discussion and Analysis (the “MD&A”) and unaudited condensed interim consolidated financial statements for the three and nine months ended December 31, 2018 are available on the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at www.canopyrivers.com/financials. “We believe that Canopy Rivers has rapidly developed a strong position in the dynamic and fast-growing global cannabis industry,” said Bruce Linton, Chairman and Chief Executive Officer of Canopy Rivers.
Canopy Rivers Inc. (RIV.V) (“Canopy Rivers” or the “Company”) is pleased to announce that it has closed its previously announced bought deal financing (the “Bought Deal”) of subordinated voting shares of the Company (the “Subordinated Voting Shares”) with a syndicate of underwriters (the “Underwriters”) led by CIBC Capital Markets (“CIBC”) and Eight Capital (together with CIBC, the “Joint Bookrunners”). The Bought Deal consisted of an aggregate of 13,225,000 Subordinated Voting Shares, which reflects the exercise in full of the Underwriters’ over-allotment option, at a price of $4.80 per Subordinated Voting Share (the “Issue Price”) for gross proceeds of approximately $63.5 million.
Although cannabis remains federally criminalized, if more US states follow in California's footsteps, this may result in an influx of investors looking to the marijuana stock market for opportunities. Nabis Holdings (INNPF) (NAB), INSYS Therapeutics Inc (INSY), CannTrust Holdings Inc (OTC PINK: CNTTF), and Canopy Rivers Inc (OTC PINK: CNPOF) (RIV.V) are four cannabis companies picking up speed on Tuesday. Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.
Mugglehead says cannabis beverages are going to be the talk of 2019. Since securing its deal with Constellation Brands, Inc. (STZ), all eyes have been on Canopy Growth and what it plans to do in the beverages space. Recently, it also announced it would be injecting an additional CAD $30 million into Canopy Rivers Inc. (RIV.V), its investing arm.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how recent developments in the EU Parliament as well as WHO (World Health Organization) could have massive impacts on the cannabis market and which companies are preparing for this next step in the radically expanding sector. In breaking news yesterday, the European Parliament passed a resolution calling on the European Commission and EU countries to provide a legal definition and draw a clear distinction between cannabis-based medicines approved by regulatory bodies, MMJ not supported by clinical trials, and other applications of the plant.
Canopy Rivers Inc. (the “Company”) (RIV.V) will report its third quarter fiscal 2019 financial results after markets close on Wednesday February 27, 2019. The Company’s unaudited condensed interim financial statements and Management’s Discussion and Analysis for the three and nine months ended December 31, 2018 will be available on the Company’s profile on SEDAR at www.sedar.com and in the Investors section of the Company’s website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC) that is currently scheduled to be released on February 14, 2019.
Precision Extraction Solutions Named Exclusive Equipment Supplier of Canapar S.r.L. DETROIT, Feb. 12, 2019 /PRNewswire/ -- Precision Extraction Solutions ("Precision"), a market leader in cannabis and hemp extraction technology, has been named the exclusive equipment supplier of Canapar S.r.L. ("Canapar") for the development and outfitting of its flagship extraction facility in Sicily, Italy. On the heels of a $25 million CAD ($20 million USD) round of financing, that included a lead investment by Canopy Rivers Inc (RIV.V), the corporate venture capital platform of Canopy Growth Corporation (TSX: WEED, NYSE: CGC), a global leader in the cannabis sector, Canapar engaged Precision for the design and manufacturing of an industrial scale hemp extraction plant.
SMITHS FALLS, ON , Feb. 7, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce that it intends to increase its total investment in Canopy Rivers Inc. ("Canopy Rivers") (RIV.V) by $30 million (CDN). The investment will be made through a private placement of subordinated voting shares in the capital of Canopy Rivers (the "Subordinate Voting Shares") concurrent with Canopy Rivers bought deal offering of Subordinate Voting Shares for gross proceeds of approximately $55 million . This investment is being co-led by CIBC Capital Markets and Eight Capital and is expected to close on or about February 27, 2019 .